Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -120.20%-1.42M | -32.01%-1.21M | -219.31%-649.01K | -68.98%-2.76M | -89.70%-990.4K | -132.05%-646.62K | -137.16%-914.9K | 54.22%-203.25K | -85.11%-1.63M | -8,512.37%-522.08K |
| Net income from continuing operations | -45.27%-1.56M | -57.06%-1.83M | 0.79%-1.06M | -147.38%-3.9M | 4.96%-592.69K | -255.49%-1.07M | -263.02%-1.16M | -224.23%-1.07M | -27.38%-1.58M | -281.23%-623.61K |
| Depreciation and amortization | --815 | --779 | --257 | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Asset impairment expenditure | 2,627.40%8.95K | -41.61%5.46K | --0 | ---317.58K | ---444.37K | ---354 | --9.35K | --117.79K | --0 | --0 |
| Remuneration paid in stock | 56.27%593.8K | 117.12%1.02M | -64.52%162.73K | 458.21%1.51M | 45.83%203.66K | 1,174.85%380K | 910.62%470.15K | 734.47%458.6K | 28.58%270.94K | 270.75%139.66K |
| Other non cashItems | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -59.15%166.23K | ---- | ---- |
| Change In working capital | -1,091.67%-468.01K | -76.46%-407.09K | -14.20%246.41K | 83.66%-53.32K | -311.78%-157K | 827.18%47.19K | -106.47%-230.71K | 269.02%287.19K | -620.49%-326.27K | -112.61%-38.13K |
| -Change in receivables | -18,031.74%-387.29K | -2,191.86%-360.46K | 961.05%69.16K | 132.99%2.33K | 350.38%13.68K | -9.26%-2.14K | -340.09%-15.73K | 205.11%6.52K | -326.55%-7.07K | -283.20%-5.46K |
| -Change in prepaid assets | -374.04%-73.22K | 140.06%10.98K | -11.94%100.24K | 158.92%69.2K | 72.29%-43.94K | 1,918.79%26.72K | -345.57%-27.42K | 133.40%113.83K | -4.35%-117.44K | -241.02%-158.59K |
| -Change in payables and accrued expense | -133.16%-7.5K | 69.28%-57.61K | -53.84%77.02K | 48.04%-117.82K | -218.60%-119.71K | 837.51%22.61K | -67.26%-187.56K | 178.52%166.84K | -219.02%-226.75K | -49.67%100.93K |
| -Change in other current liabilities | ---- | ---- | ---- | -128.13%-7.03K | ---- | ---- | ---- | ---- | 283.30%24.99K | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -120.20%-1.42M | -11.71%-1.21M | -1,653.08%-649.01K | -68.98%-2.76M | -89.70%-990.4K | -132.05%-646.62K | -36.38%-1.08M | 0.00%-37.02K | -85.11%-1.63M | -8,512.37%-522.08K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -138.04K | 250 | 222.33K | 74.76%-72.3K | -72.3K | 0 | 0 | 0 | -1,070.21%-286.4K | |
| Net PPE purchase and sale | ---138.04K | --250 | ---125.4K | 74.76%-72.3K | ---72.3K | --0 | --0 | --0 | -1,070.21%-286.4K | ---- |
| Net business purchase and sale | --0 | --0 | --347.73K | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---138.04K | --250 | --222.33K | 74.76%-72.3K | ---72.3K | --0 | --0 | --0 | -1,070.21%-286.4K | ---- |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 52.38%1.13M | -46.24%630K | 29.78%338.73K | 135.19%4.6M | 1,059.65%2.43M | 970.29%738.5K | 26.67%1.17M | -65.26%261K | 142.44%1.95M | 209.2K |
| Net common stock issuance | ---- | ---- | -57.65%72K | 322.97%3.18M | --2.18M | --0 | --824.2K | -77.38%170K | 82.75%751.4K | --0 |
| Proceeds from stock option exercised by employees | --0 | --0 | 193.10%266.73K | 21.70%1.46M | 37.31%287.25K | 970.29%738.5K | -62.42%347.6K | --91K | 204.57%1.2M | --209.2K |
| Net other financing activities | ---417K | ---- | ---- | ---45.29K | ---38.83K | --0 | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 52.38%1.13M | -46.24%630K | 29.78%338.73K | 135.19%4.6M | 1,059.65%2.43M | 970.29%738.5K | 12.18%1.17M | -58.70%261K | 142.44%1.95M | --209.2K |
| Net cash flow | ||||||||||
| Beginning cash position | 267.86%1.15M | 2,174.84%1.64M | 9,067.47%1.71M | 3,709.82%18.63K | -37.12%400.9K | -63.17%312.05K | -76.59%72.08K | 3,709.82%18.63K | -99.51%489 | 6,296.53%637.54K |
| Current changes in cash | -575.15%-436.57K | -324.80%-577.5K | -252.30%-87.95K | 4,585.14%1.77M | 327.49%1.36M | 143.83%91.88K | -52.36%256.9K | -81.21%57.75K | 138.13%37.78K | -6,222.83%-599.28K |
| Effect of exchange rate changes | -15.28%-3.49K | 606.36%85.71K | 559.80%19.75K | -310.22%-80.54K | -186.70%-56.29K | ---3.03K | ---16.93K | ---4.3K | ---19.63K | ---19.63K |
| End cash Position | 76.56%707.85K | 267.86%1.15M | 2,174.84%1.64M | 9,067.47%1.71M | 9,067.47%1.71M | -37.12%400.9K | -63.17%312.05K | -76.59%72.08K | 3,709.82%18.63K | 3,709.82%18.63K |
| Free cash from | -141.55%-1.56M | -11.69%-1.21M | -1,991.81%-774.41K | -47.50%-2.83M | -31.44%-1.06M | -132.05%-646.62K | -36.38%-1.08M | 0.00%-37.02K | -111.74%-1.92M | -8,430.05%-808.48K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.